Finished product reference

Prothrombin Complex (Concentrated)

Injection, Powder, Lyophilized, for Solution · Parenteral · 500 IU

List code
9576
Pharmacologic class
Blood coagulation factor concentrate (human, plasma-derived)

What it is and how it works

Prothrombin complex concentrate contains the vitamin K-dependent coagulation factors II, VII, IX and X (four-factor products), usually with proteins C and S, purified from human plasma. It rapidly restores these factors and normalises coagulation.

Indications

Urgent reversal of vitamin K antagonist anticoagulation (e.g. warfarin) in major bleeding or before urgent surgery; treatment and prophylaxis of bleeding in congenital or acquired deficiency of vitamin K-dependent factors when specific concentrates are unavailable.

Dosage and administration (summary)

Dosing is individualised by the specialist according to INR, body weight and clinical situation, given by slow intravenous injection; vitamin K is given concurrently for warfarin reversal.

Contraindications

Hypersensitivity to the product or heparin (if heparin-containing); history of heparin-induced thrombocytopenia for heparin-containing products; disseminated intravascular coagulation (relative).

Warnings and precautions

Risk of thromboembolic events, including in patients with coronary disease, liver disease or recent thrombosis; monitor clinically and with coagulation tests. As a plasma-derived product, transmission of infectious agents cannot be totally excluded.

Pregnancy

Use in pregnancy only if clearly needed.

Storage and supply

Store according to the manufacturer, usually at 2–25 °C; do not freeze; protect from light.

Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.

Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.

Tell us the quantity, the market and the timing.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com